The Movement Disorder Society Nonmotor Rating Scale: Initial Validation Study

Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review

(2019) Klaus Seppi et al.   MOVEMENT DISORDERS

EuroInf 2: Subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease

(2019) Haidar S. Dafsari et al.   MOVEMENT DISORDERS

Should there be less emphasis on levodopa‐induced dyskinesia in Parkinson's disease?

(2019) K. Ray Chaudhuri et al.   MOVEMENT DISORDERS

Non-motor Parkinson disease: new concepts and personalised management

(2018) Nataliya Titova et al.   MEDICAL JOURNAL OF AUSTRALIA

Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial

(2018) Regina Katzenschlager et al.   LANCET NEUROLOGY

Evaluation of nocturnal hypokinesia in Parkinson’s disease using a novel patient/proxy questionnaire and correlations with objective monitoring

(2018) Roongroj Bhidayasiri et al.   PARKINSONISM & RELATED DISORDERS

Burden of non-motor symptoms in Parkinson's disease patients predicts improvement in quality of life during treatment with levodopa-carbidopa intestinal gel

(2018) K. Ray Chaudhuri et al.   EUROPEAN JOURNAL OF NEUROLOGY

Comprehensive grading of Parkinson’s disease using motor and non-motor assessments: addressing a key unmet need

(2017) Pablo Martinez-Martin et al.   Expert Review of Neurotherapeutics

Non-motor features of Parkinson disease

(2017) Anthony H.V. Schapira et al.   NATURE REVIEWS NEUROSCIENCE

Comprehensive grading of Parkinson’s disease using motor and non-motor assessments: addressing a key unmet need

(2017) Pablo Martinez-Martin et al.   Expert Review of Neurotherapeutics

Nonmotor features of Parkinson's disease subtypes

(2016) Connie Marras et al.   MOVEMENT DISORDERS

Satisfaction with Life Scale (SLS-6): First validation study in Parkinson's disease population

(2016) Leire Ambrosio et al.   PARKINSONISM & RELATED DISORDERS

New clinical trials for nonmotor manifestations of Parkinson's disease

(2015) Anette Schrag et al.   MOVEMENT DISORDERS

MDS clinical diagnostic criteria for Parkinson's disease

(2015) Ronald B. Postuma et al.   MOVEMENT DISORDERS

Accuracy of screening instruments for detection of neuropsychiatric syndromes in Parkinson's disease

(2015) Pablo Martinez-Martin et al.   MOVEMENT DISORDERS

What sample sizes for reliability and validity studies in neurology?

(2012) Jeremy C. Hobart et al.   JOURNAL OF NEUROLOGY

The clinical global impression scale and the influence of patient or staff perspective on outcome

(2011) Thomas Forkmann et al.   BMC Psychiatry

The impact of non-motor symptoms on health-related quality of life of patients with Parkinson's disease

(2011) Pablo Martinez-Martin et al.   MOVEMENT DISORDERS

Rotigotine effects on early morning motor function and sleep in Parkinson's disease: A double-blind, randomized, placebo-controlled study (RECOVER)

(2010) Claudia Trenkwalder et al.   MOVEMENT DISORDERS

Systematic review of levodopa dose equivalency reporting in Parkinson's disease

(2010) Claire L. Tomlinson et al.   MOVEMENT DISORDERS

The MoCA: Well-suited screen for cognitive impairment in Parkinson disease

(2010) J. C. Dalrymple-Alford et al.   NEUROLOGY

Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results

(2008) Christopher G. Goetz et al.   MOVEMENT DISORDERS

The clinical impression of severity index for Parkinson's disease: International validation study

(2008) Pablo Martínez-Martín et al.   MOVEMENT DISORDERS